214 related articles for article (PubMed ID: 25220599)
21. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
22. From genome to proteome in tumor profiling: molecular events in colorectal cancer genesis.
Habermann JK; Roblick UJ; Upender M; Ried T; Auer G
Adv Exp Med Biol; 2006; 587():161-77. PubMed ID: 17163165
[TBL] [Abstract][Full Text] [Related]
23. Proteomics biomarkers for solid tumors: Current status and future prospects.
Belczacka I; Latosinska A; Metzger J; Marx D; Vlahou A; Mischak H; Frantzi M
Mass Spectrom Rev; 2019 Jan; 38(1):49-78. PubMed ID: 29889308
[TBL] [Abstract][Full Text] [Related]
24. Discovery and Validation of Clinical Biomarkers of Cancer: A Review Combining Metabolomics and Proteomics.
Srivastava A; Creek DJ
Proteomics; 2019 May; 19(10):e1700448. PubMed ID: 30353665
[TBL] [Abstract][Full Text] [Related]
25. Role of Salivary Biomarkers in Oral Cancer Detection.
Khurshid Z; Zafar MS; Khan RS; Najeeb S; Slowey PD; Rehman IU
Adv Clin Chem; 2018; 86():23-70. PubMed ID: 30144841
[TBL] [Abstract][Full Text] [Related]
26. Biomarkers in cancer screening, research and detection: present and future: a review.
Kumar S; Mohan A; Guleria R
Biomarkers; 2006; 11(5):385-405. PubMed ID: 16966157
[TBL] [Abstract][Full Text] [Related]
27. Cancer proteomics.
Tan HT; Lee YH; Chung MC
Mass Spectrom Rev; 2012; 31(5):583-605. PubMed ID: 22422534
[TBL] [Abstract][Full Text] [Related]
28. Proteomics of Colorectal Cancer in a Genomic Context: First Large-scale Mass Spectrometry-Based Analysis from the Cancer Genome Atlas.
Jimenez CR; Fijneman RJ
Clin Chem; 2015 Sep; 61(9):1126-8. PubMed ID: 25722459
[No Abstract] [Full Text] [Related]
29. Genomics and proteomics in process development: opportunities and challenges.
Gupta P; Lee KH
Trends Biotechnol; 2007 Jul; 25(7):324-30. PubMed ID: 17475353
[TBL] [Abstract][Full Text] [Related]
30. Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability.
Shrestha R; Llaurado Fernandez M; Dawson A; Hoenisch J; Volik S; Lin YY; Anderson S; Kim H; Haegert AM; Colborne S; Wong NKY; McConeghy B; Bell RH; Brahmbhatt S; Lee CH; DiMattia GE; Le Bihan S; Morin GB; Collins CC; Carey MS
Cancer Res; 2021 Apr; 81(7):1681-1694. PubMed ID: 33441310
[TBL] [Abstract][Full Text] [Related]
31. Proteomic applications for the early detection of cancer.
Wulfkuhle JD; Liotta LA; Petricoin EF
Nat Rev Cancer; 2003 Apr; 3(4):267-75. PubMed ID: 12671665
[TBL] [Abstract][Full Text] [Related]
32. Principles of proteomics and its applications in cancer.
Chuthapisith S; Layfield R; Kerr ID; Eremin O
Surgeon; 2007 Feb; 5(1):14-22. PubMed ID: 17313124
[TBL] [Abstract][Full Text] [Related]
33. Next generation sequencing technologies in cancer diagnostics and therapeutics: A mini review.
Li W; Zhao K; Kirberger M; Liao W; Yan Y
Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(5):91-102. PubMed ID: 26522064
[TBL] [Abstract][Full Text] [Related]
34. Early detection: the impact of genomics.
van Lanschot MCJ; Bosch LJW; de Wit M; Carvalho B; Meijer GA
Virchows Arch; 2017 Aug; 471(2):165-173. PubMed ID: 28573511
[TBL] [Abstract][Full Text] [Related]
35. Developing an integrated proteo-genomic approach for the characterisation of biomarkers for the identification of Bacillus anthracis.
Misra RV; Ahmod NZ; Parker R; Fang M; Shah H; Gharbia S
J Microbiol Methods; 2012 Feb; 88(2):237-47. PubMed ID: 22178189
[TBL] [Abstract][Full Text] [Related]
36. Next-generation sequencing in the clinic: promises and challenges.
Xuan J; Yu Y; Qing T; Guo L; Shi L
Cancer Lett; 2013 Nov; 340(2):284-95. PubMed ID: 23174106
[TBL] [Abstract][Full Text] [Related]
37. Optomechanical devices for deep plasma cancer proteomics.
Kosaka PM; Calleja M; Tamayo J
Semin Cancer Biol; 2018 Oct; 52(Pt 1):26-38. PubMed ID: 28867489
[TBL] [Abstract][Full Text] [Related]
38. The path to routine use of genomic biomarkers in the cancer clinic.
Boutros PC
Genome Res; 2015 Oct; 25(10):1508-13. PubMed ID: 26430161
[TBL] [Abstract][Full Text] [Related]
39. Universal Genomic Testing Needed to Win the War Against Cancer: Genomics IS the Diagnosis.
Subbiah V; Kurzrock R
JAMA Oncol; 2016 Jun; 2(6):719-20. PubMed ID: 27078832
[No Abstract] [Full Text] [Related]
40. Proteomic and genomic profiling of pancreatic cancer.
Ansari D; Torén W; Zhou Q; Hu D; Andersson R
Cell Biol Toxicol; 2019 Aug; 35(4):333-343. PubMed ID: 30771135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
